InsiderClue
Insiders · Profile

Coloma Jason V

Chief Executive Officer at Maze Therapeutics. Filing since 15 May 2026. CIK 0001676170

Company
Date
Role
Action
Shares
Amount
Of holding
MAZE Maze Therapeutics, Inc.
1 Oct 2026
Chief Executive Officer
Sold on a plan
31,908
$862.19K
14.3%
MAZE Maze Therapeutics, Inc.
1 Oct 2026
Chief Executive Officer
Sold on a plan
2,593
$70.07K
14.3%
MAZE Maze Therapeutics, Inc.
3 Sep 2026
Chief Executive Officer
Sold at will
11,411
$296.81K
29.4%
MAZE Maze Therapeutics, Inc.
2 Sep 2026
Chief Executive Officer
Sold at will
11,227
$297.15K
22.5%
MAZE Maze Therapeutics, Inc.
1 Sep 2026
Chief Executive Officer
Sold on a plan
31,908
$838.78K
12.5%
MAZE Maze Therapeutics, Inc.
1 Sep 2026
Chief Executive Officer
Sold on a plan
2,593
$68.21K
12.5%
MAZE Maze Therapeutics, Inc.
3 Aug 2026
Chief Executive Officer
Sold on a plan
34,501
$922.32K
62.5%
MAZE Maze Therapeutics, Inc.
1 Jul 2026
Chief Executive Officer
Sold on a plan
34,501
$1.03M
59.7%
MAZE Maze Therapeutics, Inc.
23 Jun 2026
Chief Executive Officer
Sold on a plan
23,865
$621.67K
7.0%
MAZE Maze Therapeutics, Inc.
22 Jun 2026
Chief Executive Officer
Sold on a plan
3,993
$103.82K
13.3%
MAZE Maze Therapeutics, Inc.
1 Jun 2026
Chief Executive Officer
Sold on a plan
6,643
$174.05K
19.2%
MAZE Maze Therapeutics, Inc.
26 May 2026
Chief Executive Officer
Sold on a plan
25,582
$665.52K
6.8%
MAZE Maze Therapeutics, Inc.
22 May 2026
Chief Executive Officer
Sold on a plan
6,982
$181.53K
19.7%
MAZE Maze Therapeutics, Inc.
15 May 2026
Chief Executive Officer
Sold on a plan
1,938
$50.39K
5.9%
14 decisions on file.